Sixth Street-backed Caris Life valued at $7.7 billion in strong Nasdaq debut
(Reuters) -Caris Life Sciences' shares jumped nearly 29% in their New York debut on Wednesday, fetch...
18th June, 2025
(Reuters) -Caris Life Sciences' shares jumped nearly 29% in their New York debut on Wednesday, fetch...
18th June, 2025
LONDON (Reuters) -Kate, Britain's Princess of Wales, will not be at Royal Ascot on Wednesday, with a...
18th June, 2025

(Reuters) -Sword Health raised $40 million in a funding round led by General Catalyst, the company s...
17th June, 2025
(Reuters) -AstraZeneca has signed a research agreement worth more than $5 billion with Chinese drugm...
13th June, 2025
(Reuters) -Novo Nordisk said on Thursday it plans to start late-stage trials of amycretin injection...
12th June, 2025
BERLIN (Reuters) -German medical technology firm Brainlab is planning an initial public offering on...
12th June, 2025

Armistice Capital, a New York-based hedge fund known for its event-driven strategy and sector-specif...
12th June, 2025
(Reuters) -Denmark's Novo Nordisk is partnering with biotech company Deep Apple Therapeutics in a de...
11th June, 2025
(Reuters) -Private equity firms KKR and Stonepeak Partners raised their offer for Britain's Assura o...
11th June, 2025
COPENHAGEN (Reuters) -Novo Nordisk has launched a new late-stage trial for its experimental next-gen...
10th June, 2025
By Amina Niasse (Reuters) -Hims & Hers Health is betting that the cash-pay market for weight-loss dr...
10th June, 2025
(Reuters) -UK's medicine regulator said on Monday it has temporarily restricted the use of French va...
9th June, 2025